Crane Company (CR) Gabelli Funds 35th Annual Pump, Valve & Water Symposium summary
Event summary combining transcript, slides, and related documents.
Gabelli Funds 35th Annual Pump, Valve & Water Symposium summary
7 Jan, 2026Strategic overview and business performance
Focused on evolving the portfolio toward higher growth, higher margin businesses, now streamlined into Aerospace & Electronics and Process Flow Technologies.
Achieved 15% sales growth and 29% increase in adjusted operating profit in 2024, with both segments contributing strongly.
Aerospace & Electronics expects 7%-9% sales CAGR through the decade; Process Flow Technologies targets 3%-5% long-term growth.
Operating profit growth is projected at about twice the rate of core sales growth, driven by disciplined execution and the Crane Business System.
Net cash position with $1B acquisition capacity today, growing to $4B by 2028, aiming to double business size in five years through organic growth and M&A.
Process Flow Technologies (PFT) focus and market positioning
PFT specializes in valves and related products for chemical, pharmaceutical, water, and industrial markets, with a $1.2B business and 21% margins.
Shifted away from oil & gas and conventional power, now with nearly two-thirds of business in higher growth markets like chemicals, water, and pharma.
Growth initiatives include innovation, new product introductions, channel management, and strategic pricing, driving both growth and margin expansion.
New product vitality has tripled in recent years, with a target of 20% of sales from products launched in the last three years.
Margin expansion driven by higher growth markets, new products, and operational improvements; segment margins have nearly doubled since 2017.
Capital deployment and M&A strategy
Strong M&A track record with four successful acquisitions since 2023; healthy pipeline for future deals.
Capital deployment focused on high-return, accretive acquisitions to strengthen growth and margin profile.
Management remains open to future portfolio moves, guided by shareholder value creation.
Latest events from Crane Company
- Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Record 2025 growth and acquisitions set up 10% adjusted EPS growth for 2026.CR
Q4 20252 Feb 2026 - Q2 sales up 14% and adjusted EPS up 18%, with raised full-year guidance and strong segment growth.CR
Q2 20242 Feb 2026 - Q3 2024 saw 13% sales growth, 34% higher EPS, and raised full-year guidance.CR
Q3 202418 Jan 2026 - Q4 adjusted EPS up 58%, sales up 12%, and 2025 guidance raised with a 12% dividend increase.CR
Q4 20249 Jan 2026 - Q1 2025 saw strong sales and profit growth, record backlog, and reaffirmed EPS guidance.CR
Q1 202525 Dec 2025 - Proxy details director elections, auditor ratification, and performance-based executive pay.CR
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting with no fee required.CR
Proxy Filing1 Dec 2025 - Q2 sales up 9.2%, adjusted EPS up 24%, guidance raised, and major PSI acquisition announced.CR
Q2 20253 Nov 2025